{
  "docId": "019de075-dd1e-7468-9323-d12fde1b7732",
  "docSlug": "a9cc0c508d45d8985f57408ace49b969",
  "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides",
  "authorId": "rayzebio",
  "authorName": "RayzeBio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 40,
  "pageCount": 41,
  "prevPage": 39,
  "nextPage": 41,
  "slideType": "unfair_advantage",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a vertical process flow to illustrate vertical integration.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/40",
  "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732",
  "deckJsonHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732.json",
  "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-40",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.25,
        "x": 0.03,
        "y": 0.27
      },
      "kind": "diagram",
      "text": "Discovery, Early Development, Clinical Development, Manufacturing, Capitalization",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c1b16cc-2be7-48d6-a969-2a3102637af2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.65,
        "x": 0.3,
        "y": 0.27
      },
      "kind": "list",
      "text": "Specialized RPT research facility (28,000 sq ft) with 500+ in vivo studies completed\nMultiple proprietary development candidates for various solid tumor indications\n225Ac clinical program in Phase 3 for GEP-NETs and in Phase 1b for SCLC\nConstructing a centralized GMP facility to supply drug product; Redundant 225Ac supply\nWell capitalized from broad set of investors",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72b53074-6152-45de-be88-81be95077919",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.95,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "We are building a vertically integrated company with RPT capabilities utilizing 225Ac spanning discovery to late-stage development to GMP manufacturing",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fcdbbd7-db80-4d30-9629-6fd4be659835",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "RayzeBio – Uniquely Positioned in the RPT Space",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "387ac6b7-8df0-4c83-a643-4655f483ccd2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "value-chain",
      "slug": null,
      "matchId": "367b7cdf-c650-4242-814a-8fce22db400b",
      "evidence": "The slide maps the company's activities from discovery to manufacturing as a vertical integration strategy.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}